Date: 2015-05-09 06:45:52Cancer organizations Immunotherapy Melanoma Cancer immunotherapy Cancer research Ipilimumab Prostate cancer Cancer vaccine James L. Gulley Medicine Cancer treatments Immunology | | MD Anderson, MedImmune join forces on immunotherapy Friday, March 14, 2014 Jim Allison, Ph.D., is executive director of the immunotherapy platform. MD Anderson and MedImmune, the global biologics research and developmentAdd to Reading ListSource URL: www.mdanderson.orgDownload Document from Source Website File Size: 240,13 KBShare Document on Facebook
|